HI HB2366

Prohibits health insurers, mutual benefit societies, and health maintenance organizations from imposing cost-sharing requirements (deductibles, copays, coinsurance) on breast cancer screenings, supplemental breast examinations, and diagnostic breast examinations.

Supplemental breast examinations cover screenings for individuals without abnormalities but with elevated risk due to personal or family medical history, including MRI, ultrasound, contrast-enhanced mammography, and molecular breast imaging.

Diagnostic breast examinations cover follow-up evaluations of abnormalities detected during screening or other examinations, following National Comprehensive Cancer Network Guidelines.

Includes an exception for high deductible health plans to maintain cost-sharing at the minimum level necessary to preserve eligibility for health savings accounts under IRS Section 223.

Takes effect January 1, 2027, applying to all health insurance plans issued or renewed on or after that date.